South San Francisco, CA, United States of America

Jennifer Eng-Wong

This inventor holds 2 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Genentech, Inc., Hoffmann-La Roche Inc.. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Eng-Wong. Retrieved from https://idiyas.com/inventor/jennifer-eng-wong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jennifer Eng-Wong

Introduction

Jennifer Eng-Wong is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the field of cancer treatment through her innovative work on HER2 antibody formulations. With a total of 2 patents, her research has the potential to improve the lives of many patients battling cancer.

Latest Patents

Jennifer's latest patents focus on subcutaneous HER2 antibody formulations. These fixed-dose formulations are designed for subcutaneous administration and are aimed at enhancing the treatment of cancer. The formulations include fixed-dose subcutaneous versions of pertuzumab, as well as co-formulations of pertuzumab and trastuzumab. These advancements represent a significant step forward in cancer therapy, providing new options for patients.

Career Highlights

Throughout her career, Jennifer has worked with leading companies in the pharmaceutical industry, including Genentech, Inc. and Hoffmann-La Roche Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to the advancement of cancer treatment.

Collaborations

Jennifer has collaborated with notable professionals in her field, including Amit Garg and Tarik Ali Khan. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking solutions in cancer therapy.

Conclusion

Jennifer Eng-Wong's contributions to the field of cancer treatment through her innovative HER2 antibody formulations highlight her dedication to improving patient outcomes. Her work exemplifies the impact that inventors can have on healthcare and underscores the importance of continued research and innovation in this vital area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…